GLP-1s Increase Risk Of Osteoporosis And Gout; Novo Nordisk Failed To Report Deaths To FDA
A new research study on GLP-1 weight loss and diabetes drugs has found an increased risk of osteoporosis and gout. There was a 30% higher chance of osteoporosis and a 100% higher chance of osteomalacia for GLP-1 users compared to non-users. There was also a 12% higher risk of gout for GLP-1 users. Researchers conducted…Continue reading GLP-1s Increase Risk Of Osteoporosis And Gout; Novo Nordisk Failed To Report Deaths To FDA
